These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 21822537)
1. Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice. Tian M; Asp ML; Nishijima Y; Belury MA Int J Oncol; 2011 Nov; 39(5):1321-6. PubMed ID: 21822537 [TBL] [Abstract][Full Text] [Related]
2. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model. Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652 [TBL] [Abstract][Full Text] [Related]
3. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Zhou X; Wang JL; Lu J; Song Y; Kwak KS; Jiao Q; Rosenfeld R; Chen Q; Boone T; Simonet WS; Lacey DL; Goldberg AL; Han HQ Cell; 2010 Aug; 142(4):531-43. PubMed ID: 20723755 [TBL] [Abstract][Full Text] [Related]
4. Cardiac alterations in cancer-induced cachexia in mice. Tian M; Nishijima Y; Asp ML; Stout MB; Reiser PJ; Belury MA Int J Oncol; 2010 Aug; 37(2):347-53. PubMed ID: 20596662 [TBL] [Abstract][Full Text] [Related]
5. Atrophic remodeling of the transplanted rat heart. Sharma S; Ying J; Razeghi P; Stepkowski S; Taegtmeyer H Cardiology; 2006; 105(2):128-36. PubMed ID: 16391472 [TBL] [Abstract][Full Text] [Related]
6. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice. Peters SJ; van Helvoort A; Kegler D; Argilès JM; Luiking YC; Laviano A; van Bergenhenegouwen J; Deutz NE; Haagsman HP; Gorselink M; van Norren K Oncol Rep; 2011 Jul; 26(1):247-54. PubMed ID: 21503587 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Asp ML; Tian M; Wendel AA; Belury MA Int J Cancer; 2010 Feb; 126(3):756-63. PubMed ID: 19634137 [TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice. Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608 [TBL] [Abstract][Full Text] [Related]
9. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237 [TBL] [Abstract][Full Text] [Related]
10. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia. Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111 [TBL] [Abstract][Full Text] [Related]
11. Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia. Devine RD; Bicer S; Reiser PJ; Velten M; Wold LE Am J Physiol Heart Circ Physiol; 2015 Aug; 309(4):H685-91. PubMed ID: 26092976 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice. Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591 [TBL] [Abstract][Full Text] [Related]
13. Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? Penna F; Bonetto A; Muscaritoli M; Costamagna D; Minero VG; Bonelli G; Rossi Fanelli F; Baccino FM; Costelli P Int J Cancer; 2010 Oct; 127(7):1706-17. PubMed ID: 20039316 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms to explain wasting of muscle and fat in cancer cachexia. Argilés JM; López-Soriano FJ; Busquets S Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice. Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114 [TBL] [Abstract][Full Text] [Related]
16. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia. Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031 [TBL] [Abstract][Full Text] [Related]
17. An integrative transcriptome study reveals Ddit4/Redd1 as a key regulator of cancer cachexia in rodent models. Niu M; Li L; Su Z; Wei L; Pu W; Zhao C; Ding Y; Wazir J; Cao W; Song S; Gao Q; Wang H Cell Death Dis; 2021 Jun; 12(7):652. PubMed ID: 34175899 [TBL] [Abstract][Full Text] [Related]
18. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia. Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776 [TBL] [Abstract][Full Text] [Related]